ABK BIOMEDICAL INC

Profile

Company Names

ABK BIOMEDICAL INC

Addresses

155 CHAIN LAKE DRIVE, UNIT 32, HALIFAX, A5 B3S 1B3

155 CHAIN LAKE DR., UNIT 32, HALIFAX, A5 B3S 1B3

Phone Numbers

902-442-4009

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NOVA SCOTIA, CANADA

Total Amount Raised:

$98,738,454.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-14 
$2,558,896.00 
$2,558,896.00 
$0.00 
Equity 
4
2025-04-29 
$26,093,999.00 
$26,093,999.00 
$0.00 
Equity 
3
2022-12-05 
$28,498,880.00 
$28,498,880.00 
$0.00 
Equity 
2
2022-09-09 
$18,086,680.00 
$18,086,680.00 
$0.00 
Equity 
1
2019-04-08 
$23,499,999.00 
$23,499,999.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BOB 
 
ABRAHAM 
EXECUTIVE OFFICER, DIRECTOR
ABK BIOMEDICAL INC
ARAVIND 
 
AREPALLY 
EXECUTIVE OFFICER
SUREFIRE MEDICAL, INC.   |  ABK BIOMEDICAL INC
LUCY 
 
BATANEANT 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
AARON 
 
BEREZ 
DIRECTOR
SAPHEON, INC.   |  C2 THERAPEUTICS INC   |  AVAILS MEDICAL, INC.   |  ANALYTICS FOR LIFE, INC.   |  ABK BIOMEDICAL INC   |  ANALYTICS FOR LIFE INC.
CARISSA 
 
BLACK 
DIRECTOR
ABK BIOMEDICAL INC
CARISSA 
BELLARDINE 
BLACK 
DIRECTOR
ABK BIOMEDICAL INC
DAVID 
 
DOBROWSKI 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
DAVID 
 
DOBROWSKY 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
GARY 
 
DONOFRIO 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
JAMES 
 
EADIE 
DIRECTOR
CLARET MEDICAL, INC.   |  TVA MEDICAL, INC.   |  IOWA APPROACH, INC.   |  MILLIPEDE, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  FARAPULSE, INC.   |  DYAMX, INC.   |  GENEOS THERAPEUTICS, INC.   |  REPRIEVE CARDIOVASCULAR, INC.   |  PULSEON, INC.   |  RAPIDPULSE, INC.   |  ENDOGENEX, INC.   |  ABK BIOMEDICAL INC   |  CRYOSA, INC.
MARC 
 
GREGOIRE 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
ANTHONY 
 
HEADLEY 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
MICHAEL 
 
MANGANO 
EXECUTIVE OFFICER, DIRECTOR
RESHAPE MEDICAL, INC.   |  ABK BIOMEDICAL INC
JAMES 
 
MCLAREN 
DIRECTOR
ANALYTICS FOR LIFE, INC.   |  ABK BIOMEDICAL INC   |  ANALYTICS FOR LIFE INC.
ROBERT 
 
ORR 
DIRECTOR
RIO CAP ONSHORE, L.P.   |  OPEN BLUE SEA FARMS, INC.   |  OPEN BLUE GLOBAL SERVICES INC.   |  BAJA AQUACULTURE, INC.   |  ROSE CANYON FISHERIES, INC.   |  INNOVASEA SYSTEMS, INC.   |  ARTHROSI THERAPEUTICS, INC.   |  HALLUX, INC.   |  ABK BIOMEDICAL INC   |  CENTURION APARTMENT REIT US LP
KETAN 
 
PATEL 
DIRECTOR
INTELLEFLEX CORP   |  SHOPWELL SOLUTIONS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  RAINMAKER HOLDINGS II, LLC   |  IVENIX, INC.   |  GENOA PHARMACEUTICALS, INC.   |  NFLECTION THERAPEUTICS, INC.   |  MENLO THERAPEUTICS, INC.   |  AMPHORA MEDICAL, INC.   |  FOREST CITY REALTY TRUST, INC.   |  AZAD ALLIANCE 2019 LLC   |  AVALYN PHARMA INC.   |  RALLYBIO HOLDINGS, LLC   |  REDIRECT HEALTH, LLC   |  FOREST CITY ENTERPRISES, L.P.   |  AVIVOMED INC.   |  ABK BIOMEDICAL INC   |  FC 1275 NJ MEMBER LLC   |  FC TOD MF II HOLDINGS LLC   |  FC TOD BTR HOLDINGS I LLC   |  COMANCHE BIOPHARMA CORP.   |  LOS ANGELES BIOSCIENCES, INC.   |  RAINMAKER CAPITAL LLC
KETEN 
 
PATEL 
DIRECTOR
ABK BIOMEDICAL INC
JOSEPH 
 
SILETTO 
DIRECTOR
REFLEXION PHARMACEUTICALS, INC.   |  PREVENTICE SOLUTIONS, INC.   |  SERA PROGNOSTICS, INC.   |  SWIFT HEALTH SYSTEMS INC.   |  SCIENTIA VASCULAR, INC.   |  ABK BIOMEDICAL INC
MICHAEL 
 
TYSON 
EXECUTIVE OFFICER
AQUESYS INC   |  ABK BIOMEDICAL INC
MIKE 
 
TYSON 
EXECUTIVE OFFICER
ABK BIOMEDICAL INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-03
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-14 
2025-05-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-29 
2022-12-22
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-05 
2022-09-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-09 
2019-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#